А. И. Карселадзе

1.3k total citations
46 papers, 1.0k citations indexed

About

А. И. Карселадзе is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, А. И. Карселадзе has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in А. И. Карселадзе's work include Ovarian cancer diagnosis and treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Breast Cancer Treatment Studies (5 papers). А. И. Карселадзе is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Breast Cancer Treatment Studies (5 papers). А. И. Карселадзе collaborates with scholars based in Russia, United States and United Kingdom. А. И. Карселадзе's co-authors include Irina Budunova, Thomas J. Slaga, Ya Juan Yao, Dariusz Kowalczyk, Alexander V. Gasparian, Alexander Yemelyanov, Lawrence M. Roth, Daniëlle de Jong, Károly Szuhai and Pancras C.W. Hogendoorn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Clinical Cancer Research.

In The Last Decade

А. И. Карселадзе

37 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. И. Карселадзе Russia 14 436 339 296 205 136 46 1.0k
Earl Lawrence United States 12 733 1.7× 135 0.4× 257 0.9× 320 1.6× 83 0.6× 14 1.5k
Maria Concetta Faniello Italy 22 719 1.6× 194 0.6× 361 1.2× 182 0.9× 76 0.6× 55 1.2k
Shujun Lin China 16 822 1.9× 206 0.6× 179 0.6× 354 1.7× 171 1.3× 49 1.4k
Quan Li China 14 551 1.3× 212 0.6× 231 0.8× 169 0.8× 53 0.4× 45 1.1k
Ming Qiu China 16 591 1.4× 124 0.4× 146 0.5× 386 1.9× 86 0.6× 35 1.0k
Inmaculada Ibañez de Cáceres Spain 21 1.3k 3.1× 327 1.0× 579 2.0× 254 1.2× 76 0.6× 55 1.8k
Ki Cheol Park South Korea 23 673 1.5× 180 0.5× 184 0.6× 333 1.6× 150 1.1× 49 1.4k
Jian Bai China 19 529 1.2× 131 0.4× 264 0.9× 192 0.9× 107 0.8× 68 1.0k
Wookyeom Yang South Korea 16 254 0.6× 121 0.4× 112 0.4× 310 1.5× 57 0.4× 26 788
Xiaoli Zhang China 19 760 1.7× 91 0.3× 240 0.8× 194 0.9× 96 0.7× 45 1.0k

Countries citing papers authored by А. И. Карселадзе

Since Specialization
Citations

This map shows the geographic impact of А. И. Карселадзе's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. И. Карселадзе with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. И. Карселадзе more than expected).

Fields of papers citing papers by А. И. Карселадзе

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. И. Карселадзе. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. И. Карселадзе. The network helps show where А. И. Карселадзе may publish in the future.

Co-authorship network of co-authors of А. И. Карселадзе

This figure shows the co-authorship network connecting the top 25 collaborators of А. И. Карселадзе. A scholar is included among the top collaborators of А. И. Карселадзе based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. И. Карселадзе. А. И. Карселадзе is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Карселадзе, А. И., et al.. (2021). On terminology and topographic classification of the lingual lymph nodes. SHILAP Revista de lepidopterología. 11(4). 86–96. 1 indexed citations
3.
Карселадзе, А. И., et al.. (2021). Практические рекомендации по лечению пограничных опухолей яичников. Malignant tumours. 10(3s2-1). 210–220.
4.
Карселадзе, А. И., et al.. (2021). Surgical treatment of recurrent borderline serous ovarian tumor. Voprosy Onkologii. 67(4). 538–546.
5.
Карселадзе, А. И., et al.. (2020). Combined anti‑HER2 and hormonal treatment in a patient with HR+HER2+ clear‑cell uterine carcinoma: A case report. Molecular and Clinical Oncology. 14(1). 19–19. 1 indexed citations
6.
Карселадзе, А. И., et al.. (2020). Morphology classification of liver tumors (comparison of the last and previous WHO classifications 2010 and 2019). Medical Visualization. 24(2). 138–143. 1 indexed citations
7.
Савелов, Н. А., А. И. Карселадзе, A. Tryakin, et al.. (2016). Nuclear Protein of the Testis Midline Carcinoma Masquerading as a Primary Mediastinal Seminoma. Rare Tumors. 8(2). 85–87. 3 indexed citations
8.
Карселадзе, А. И., et al.. (2016). Neuroblastoma: morphological pattern, molecular genetic features, and prognostic factors. Advances in molecular oncology. 3(1). 32–43. 3 indexed citations
9.
Карселадзе, А. И.. (2016). Intraepithelial ischemia is a principal factor promoting cancerization of the covering epithelial tissues. Medical Hypotheses. 94. 154–160. 1 indexed citations
10.
Machado, Isidro, Antonio Pellı́n, Samuel Navarro, et al.. (2016). Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. Annals of Diagnostic Pathology. 22. 25–32. 43 indexed citations
11.
Карселадзе, А. И., et al.. (2014). A CASE OF COMPLETE RECOVERY OF DISSEMINATED RENAL ALLOGRAFT TUMOR. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Velde, Cornelis J.�H. van de, et al.. (2014). BIoLoGIcAL AND PRoGNoSTIc RoLE oF TuMoR SIZE (T 1a , T 1b , T 1c ) IN STAGE I BREAST cANcER (ExPERIENcE oF INTERNATIoNAL cooPERATIoN). 6. 1 indexed citations
13.
Poddubnaya, I V, et al.. (2014). The evolution of the local and System therapy of breast cancer stage i: 27-years’s data analysis. 6. 1 indexed citations
14.
Карселадзе, А. И., et al.. (2012). Серозные пограничные опухоли яичников (клиническое течение, морфология, лечение). SHILAP Revista de lepidopterología. 165–168. 1 indexed citations
15.
Sajet, Anita, Gerrit‐Jan Liefers, Esther Bastiaannet, et al.. (2012). Прогностическое значение возраста больных при раннем раке молочной железы. 1 indexed citations
16.
Szuhai, Károly, Marije IJszenga, Daniëlle de Jong, et al.. (2009). The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology. Clinical Cancer Research. 15(7). 2259–2268. 154 indexed citations
17.
Карселадзе, А. И., et al.. (2009). [HERV-K-associated carcinogenesis: co-expression of viral and cellular proteins in the development of human germ-cell tumors].. PubMed. 54(2). 21–6. 2 indexed citations
18.
Navarro, S., А. И. Карселадзе, Asya Smirnov, et al.. (2007). Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.. PubMed. 27(4B). 2457–63. 11 indexed citations
19.
Yemelyanov, Alexander, Paul F. Lindholm, Lenny Dang, et al.. (2005). Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene. 25(3). 387–398. 99 indexed citations
20.
Gasparian, Alexander V., Ya Juan Yao, Dariusz Kowalczyk, et al.. (2002). The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells. Journal of Cell Science. 115(1). 141–151. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026